Talecris Biotherapeutics Announces Record Date for 2011 Annual Meeting of Shareholders

RESEARCH TRIANGLE PARK, N.C., March 4, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today that its Board of Directors selected March 11, 2011 as the record date for determining stockholders entitled to vote at the 2011 Annual Meeting of Stockholders. The annual meeting will be held on May 3, 2011 at 9:00 a.m. Eastern Time at the Rizzo Conference Center, 150 DuBose House Lane, Chapel Hill, North Carolina.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics Holdings Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED